These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 3964)
1. Control of renin release: a review of experimental evidence and clinical implications. Zanchetti A; Stella A; Leonetti G; Morganti A; Terzoli L Am J Cardiol; 1976 Mar; 37(4):675-91. PubMed ID: 3964 [TBL] [Abstract][Full Text] [Related]
2. Effect of antihypertensive drugs on the renin-angiotensin system. Johnston CI Drugs; 1976; 12(4):274-91. PubMed ID: 786609 [TBL] [Abstract][Full Text] [Related]
3. Neural regulation of renin release: experimental evidence and clinical implications in arterial hypertension. Zanchetti AS Circulation; 1977 Nov; 56(5):691-8. PubMed ID: 912827 [TBL] [Abstract][Full Text] [Related]
4. Pathophysiology of propranolol in hypertension. Frohlich ED South Med J; 1977 Jan; 70(1):95-9. PubMed ID: 14402 [TBL] [Abstract][Full Text] [Related]
5. Antihypertensive therapy: newer concepts and agents. Frohlich ED Cardiology; 1985; 72(5-6):349-65. PubMed ID: 2866842 [TBL] [Abstract][Full Text] [Related]
6. Drug therapy of hypertension: what we have, what we need, what we expect. Gross F Am J Cardiol; 1974 Oct; 34(4):471-5. PubMed ID: 4153317 [No Abstract] [Full Text] [Related]
7. Adrenergic regulation of renin release and effects on angiotensin and aldosterone. Karlberg BE Acta Med Scand Suppl; 1983; 672():33-40. PubMed ID: 6138931 [TBL] [Abstract][Full Text] [Related]
9. Neural control of renin release. Zanchetti A; Stella A Clin Sci Mol Med Suppl; 1975 Jun; 2():215s-223s. PubMed ID: 802638 [TBL] [Abstract][Full Text] [Related]
10. [Pharmacological basis of antihypertensive drug therapy]. Kolck UW; Zaugg CE; Erne P Praxis (Bern 1994); 2004 May; 93(20):847-56. PubMed ID: 15195836 [TBL] [Abstract][Full Text] [Related]
11. [Hemodynamic and hormonologic basis of the treatment of arterial hypertension]. Guédon J; Lucsko M; Chaignon M Arch Mal Coeur Vaiss; 1974 Oct; 67(10):1145-55. PubMed ID: 4156640 [TBL] [Abstract][Full Text] [Related]
12. Development and trends in the drug treatment of essential hypertension. van Zwieten PA J Hypertens Suppl; 1992 Dec; 10(7):S1-12. PubMed ID: 1363322 [TBL] [Abstract][Full Text] [Related]
13. Can we develop new drugs for hypertension? Gross F Br J Clin Pharmacol; 1982 Jan; 13(1):133-6. PubMed ID: 6121571 [No Abstract] [Full Text] [Related]
15. Tailoring the antihypertensive drug regimen. Amadio P; Cummings DM; Amadio PB Am Fam Physician; 1986 Aug; 34(2):157-70. PubMed ID: 2875638 [TBL] [Abstract][Full Text] [Related]
16. The Role of Beta-Blockers in the Treatment of Hypertension. Cruickshank JM Adv Exp Med Biol; 2017; 956():149-166. PubMed ID: 27957711 [TBL] [Abstract][Full Text] [Related]
17. The plasma renin test reveals the contribution of body sodium-volume content (V) and renin-angiotensin (R) vasoconstriction to long-term blood pressure. Laragh JH; Sealey JE Am J Hypertens; 2011 Nov; 24(11):1164-80. PubMed ID: 21938070 [TBL] [Abstract][Full Text] [Related]
19. Renin release, saralasin and the vasodilator-beta-blocker drug interaction in man. Pettinger WA; Mitchell HC N Engl J Med; 1975 Jun; 292(23):1214-7. PubMed ID: 236513 [TBL] [Abstract][Full Text] [Related]
20. [Combination of betablocking-vasodilator and diuretic agents in the treatment of arterial hypertension. Changes in Hemodynamics and plasma-renin levels]. Fernández-Andrade C; Herrera Carranza M; Villalobos Galán E; Mateos Aguilar J; Quereda C; Navarro R; Martinez Martin A; Mendoza Llera M Rev Clin Esp; 1978 Mar; 148(5):491-6. PubMed ID: 27844 [No Abstract] [Full Text] [Related] [Next] [New Search]